James Kihara News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James kihara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Kihara Today - Breaking & Trending Today

Seven Eight Capital LP Raises Stock Position in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Seven Eight Capital LP grew its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) by 15.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 66,207 shares of the biopharmaceutical company’s stock after buying an additional 8,908 shares during the period. Seven Eight […] ....

United States , Stifel Nicolaus , Stephen Davis , James Kihara , Pharmaceuticals Inc , Campbell Co Investment Adviser , Rafferty Asset Management , Morgan Stanley , Securities Exchange Commission , Investment Management , Pharmaceuticals Trading Down , Cantor Fitzgerald , Pharmaceuticals Daily , Royal Bank , First Trust Advisors , Seven Eight Capital , Free Report , Eight Capital , Trust Advisors , Asset Management , Trading Down , Get Free Report , Exchange Commission , Visit Holdingschannel ,

ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 52-Week Low at $14.60

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $14.60 and last traded at $14.68, with a volume of 628880 shares traded. The stock had previously closed at $15.09. Analysts Set New Price Targets Several brokerages have […] ....

United States , James Kihara , Markc Schneyer , Jpmorgan Chase Co , Shell Asset Management Co , Covestor Ltd , Headlands Technologies , Quest Partners , Pharmaceuticals Daily , Pharmaceuticals Inc , Pharmaceuticals Price Performance , Royal Bank , Acadia Pharmaceuticals Inc , Get Free Report , Management Fondsmaeglerselskab , Shell Asset Management , Asset Management ,

Short Interest in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Rises By 7.8%

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 12,030,000 shares, an increase of 7.8% from the April 15th total of 11,160,000 shares. Based on an average trading volume of 1,810,000 shares, the short-interest ratio […] ....

United States , James Kihara , Stifel Nicolaus , Brendan Teehan , Acadia Pharmaceuticals Inc , Covestor Ltd , Pharmaceuticals Company Profile , Headlands Technologies , Royal Bank , Pharmaceuticals Trading Down , Pharmaceuticals Daily , Pharmaceuticals Inc , Shell Asset Management Co , Quest Partners , Get Free Report , Trading Down , Management Fondsmaeglerselskab , Shell Asset Management , Asset Management ,